Global Thrombin (Human) Market Insights, Forecast to 2025
- QYR2835089
- 111 Pages
- September 2018
- Medical Devices
This research report categorizes the global Thrombin (Human) market by top players/brands, region, type and end user. This report also studies the global Thrombin (Human) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The global Thrombin (Human) market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Thrombin (Human) market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Market size by Product
500IU/Vial
1000IU/Vial
2500IU/Vial
Market size by End User
Biotechnology
Medicine
Microbiology
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Thrombin (Human) market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Thrombin (Human) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Thrombin (Human) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Thrombin (Human) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Thrombin (Human) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Thrombin (Human) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Thrombin (Human) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Thrombin (Human) Market Size Growth Rate by Product
1.4.2 500IU/Vial
1.4.3 1000IU/Vial
1.4.4 2500IU/Vial
1.5 Market by End User
1.5.1 Global Thrombin (Human) Market Size Growth Rate by End User
1.5.2 Biotechnology
1.5.3 Medicine
1.5.4 Microbiology
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Thrombin (Human) Market Size
2.1.1 Global Thrombin (Human) Revenue 2013-2025
2.1.2 Global Thrombin (Human) Sales 2013-2025
2.2 Thrombin (Human) Growth Rate by Regions
2.2.1 Global Thrombin (Human) Sales by Regions
2.2.2 Global Thrombin (Human) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Thrombin (Human) Sales by Manufacturers
3.1.1 Thrombin (Human) Sales by Manufacturers
3.1.2 Thrombin (Human) Sales Market Share by Manufacturers
3.1.3 Global Thrombin (Human) Market Concentration Ratio (CR5 and HHI)
3.2 Thrombin (Human) Revenue by Manufacturers
3.2.1 Thrombin (Human) Revenue by Manufacturers (2013-2018)
3.2.2 Thrombin (Human) Revenue Share by Manufacturers (2013-2018)
3.3 Thrombin (Human) Price by Manufacturers
3.4 Thrombin (Human) Manufacturing Base Distribution, Product Types
3.4.1 Thrombin (Human) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Thrombin (Human) Product Type
3.4.3 Date of International Manufacturers Enter into Thrombin (Human) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Thrombin (Human) Sales by Product
4.2 Global Thrombin (Human) Revenue by Product
4.3 Thrombin (Human) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Thrombin (Human) Breakdown Data by End User
6 North America
6.1 North America Thrombin (Human) by Countries
6.1.1 North America Thrombin (Human) Sales by Countries
6.1.2 North America Thrombin (Human) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Thrombin (Human) by Product
6.3 North America Thrombin (Human) by End User
7 Europe
7.1 Europe Thrombin (Human) by Countries
7.1.1 Europe Thrombin (Human) Sales by Countries
7.1.2 Europe Thrombin (Human) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Thrombin (Human) by Product
7.3 Europe Thrombin (Human) by End User
8 Asia Pacific
8.1 Asia Pacific Thrombin (Human) by Countries
8.1.1 Asia Pacific Thrombin (Human) Sales by Countries
8.1.2 Asia Pacific Thrombin (Human) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Thrombin (Human) by Product
8.3 Asia Pacific Thrombin (Human) by End User
9 Central & South America
9.1 Central & South America Thrombin (Human) by Countries
9.1.1 Central & South America Thrombin (Human) Sales by Countries
9.1.2 Central & South America Thrombin (Human) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Thrombin (Human) by Product
9.3 Central & South America Thrombin (Human) by End User
10 Middle East and Africa
10.1 Middle East and Africa Thrombin (Human) by Countries
10.1.1 Middle East and Africa Thrombin (Human) Sales by Countries
10.1.2 Middle East and Africa Thrombin (Human) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Thrombin (Human) by Product
10.3 Middle East and Africa Thrombin (Human) by End User
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Company Business Overview
11.1.3 Baxter Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Baxter Thrombin (Human) Products Offered
11.1.5 Baxter Recent Development
11.2 AMRESCO Inc
11.2.1 AMRESCO Inc Company Details
11.2.2 Company Business Overview
11.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.2.4 AMRESCO Inc Thrombin (Human) Products Offered
11.2.5 AMRESCO Inc Recent Development
11.3 BD Biosciences
11.3.1 BD Biosciences Company Details
11.3.2 Company Business Overview
11.3.BD Biosciences Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.3.4 BD Biosciences Thrombin (Human) Products Offered
11.3.5 BD Biosciences Recent Development
11.4 Life Technologies Corporation
11.4.1 Life Technologies Corporation Company Details
11.4.2 Company Business Overview
11.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Life Technologies Corporation Thrombin (Human) Products Offered
11.4.5 Life Technologies Corporation Recent Development
11.5 PromoCell GmbH
11.5.1 PromoCell GmbH Company Details
11.5.2 Company Business Overview
11.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.5.4 PromoCell GmbH Thrombin (Human) Products Offered
11.5.5 PromoCell GmbH Recent Development
11.6 Sigma-Aldrich Corporation
11.6.1 Sigma-Aldrich Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Sigma-Aldrich Corporation Thrombin (Human) Products Offered
11.6.5 Sigma-Aldrich Corporation Recent Development
11.7 Vitrolife AB
11.7.1 Vitrolife AB Company Details
11.7.2 Company Business Overview
11.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Vitrolife AB Thrombin (Human) Products Offered
11.7.5 Vitrolife AB Recent Development
11.8 CSL
11.8.1 CSL Company Details
11.8.2 Company Business Overview
11.8.3 CSL Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.8.4 CSL Thrombin (Human) Products Offered
11.8.5 CSL Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Business Overview
11.9.3 Bayer Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Bayer Thrombin (Human) Products Offered
11.9.5 Bayer Recent Development
11.10 Grifols
11.10.1 Grifols Company Details
11.10.2 Company Business Overview
11.10.3 Grifols Thrombin (Human) Sales, Revenue and Gross Margin (2013-2018)
11.10.4 Grifols Thrombin (Human) Products Offered
11.10.5 Grifols Recent Development
11.11 Octapharma
11.12 Shanghai RAAS
11.13 Hualan Biological
12 Future Forecast
12.1 Thrombin (Human) Market Forecast by Regions
12.1.1 Global Thrombin (Human) Sales Forecast by Regions 2018-2025
12.1.2 Global Thrombin (Human) Revenue Forecast by Regions 2018-2025
12.2 Thrombin (Human) Market Forecast by Product
12.2.1 Global Thrombin (Human) Sales Forecast by Product 2018-2025
12.2.2 Global Thrombin (Human) Revenue Forecast by Product 2018-2025
12.3 Thrombin (Human) Market Forecast by End User
12.4 North America Thrombin (Human) Forecast
12.5 Europe Thrombin (Human) Forecast
12.6 Asia Pacific Thrombin (Human) Forecast
12.7 Central & South America Thrombin (Human) Forecast
12.8 Middle East and Africa Thrombin (Human) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Thrombin (Human) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Thrombin (Human) Product Picture
Table Thrombin (Human) Market Segments
Table Key Manufacturers Thrombin (Human) Covered
Table Global Thrombin (Human) Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Thrombin (Human) Sales Market Share by Product 2013-2025
Figure 500IU/Vial Product Picture
Table Major Manufacturers of 500IU/Vial
Figure 1000IU/Vial Product Picture
Table Major Manufacturers of 1000IU/Vial
Figure 2500IU/Vial Product Picture
Table Major Manufacturers of 2500IU/Vial
Table Global Thrombin (Human) Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Biotechnology
Figure Medicine
Figure Microbiology
Figure Other
Figure Thrombin (Human) Report Years Considered
Figure Global Thrombin (Human) Market Size 2013-2025 (Million US$)
Figure Global Thrombin (Human) Sales 2013-2025 (K Units)
Table Global Thrombin (Human) Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Thrombin (Human) Sales by Regions 2013-2018 (K Units)
Table Global Thrombin (Human) Sales Market Share by Regions 2013-2018
Figure Global Thrombin (Human) Sales Market Share by Regions 2013-2018
Figure 2017 Global Thrombin (Human) Sales Market Share by Regions
Table Global Thrombin (Human) Revenue by Regions 2013-2018 (Million US$)
Table Global Thrombin (Human) Revenue Market Share by Regions 2013-2018
Figure Global Thrombin (Human) Revenue Market Share by Regions 2013-2018
Figure 2017 Global Thrombin (Human) Revenue Market Share by Regions
Table Global Thrombin (Human) Sales by Manufacturers (2013-2018) (K Units)
Table Global Thrombin (Human) Sales Share by Manufacturers (2013-2018)
Figure Global Thrombin (Human) Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Thrombin (Human) Revenue by Manufacturers (2013-2018) (Million USD)
Table Thrombin (Human) Revenue Share by Manufacturers (2013-2018)
Figure Thrombin (Human) Value Share by Manufacturers in 2017
Table Key Manufacturers Thrombin (Human) Price (2013-2018) (USD/Unit)
Table Thrombin (Human) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Thrombin (Human) Product Type
Table Date of International Manufacturers Enter into Thrombin (Human) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Thrombin (Human) Sales by Product (2013-2018) (K Units)
Table Global Thrombin (Human) Sales Share by Product (2013-2018)
Figure Global Thrombin (Human) Sales Market Share by Product (2013-2018)
Figure Global Thrombin (Human) Sales Market Share by Product in 2017
Table Global Thrombin (Human) Revenue by Product (2013-2018) (Million US$)
Table Global Thrombin (Human) Revenue Share by Product (2013-2018)
Figure Global Thrombin (Human) Revenue Market Share by Product (2013-2018)
Figure Global Thrombin (Human) Revenue Market Share by Product in 2017
Table Thrombin (Human) Price by Product 2013-2018 (USD/Unit)
Table Global Thrombin (Human) Sales by End User (2013-2018) (K Units)
Table Global Thrombin (Human) Sales Share by End User (2013-2018)
Figure Global Sales Thrombin (Human) Market Share by End User (2013-2018)
Figure Global Sales Thrombin (Human) Market Share by End User in 2017
Figure North America Thrombin (Human) Sales Growth Rate 2013-2018 (K Units)
Figure North America Thrombin (Human) Revenue Growth Rate 2013-2018 (Million US$)
Table North America Thrombin (Human) Sales by Countries (2013-2018) (K Units)
Table North America Thrombin (Human) Sales Market Share by Countries (2013-2018)
Figure 2017 North America Thrombin (Human) Sales Market Share by Countries
Table North America Thrombin (Human) Revenue by Countries (2013-2018) (Million US$)
Table North America Thrombin (Human) Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Thrombin (Human) Revenue Market Share by Countries
Figure United States Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure United States Thrombin (Human) Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Canada Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Table North America Thrombin (Human) Sales by Product (2013-2018) (K Units)
Table North America Thrombin (Human) Sales Market Share by Product (2013-2018)
Figure 2017 North America Thrombin (Human) Market Share by Product
Table North America Thrombin (Human) Sales by End User (2013-2018) (K Units)
Table North America Thrombin (Human) Sales Market Share by End User (2013-2018)
Figure 2017 North America Thrombin (Human) Market Share by End User
Figure Europe Thrombin (Human) Sales Growth Rate 2013-2018 (K Units)
Figure Europe Thrombin (Human) Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Thrombin (Human) Sales by Countries (2013-2018) (K Units)
Table Europe Thrombin (Human) Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Thrombin (Human) Sales Market Share by Countries
Table Europe Thrombin (Human) Revenue by Countries (2013-2018) (Million US$)
Table Europe Thrombin (Human) Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Thrombin (Human) Revenue Market Share by Countries
Figure Germany Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Germany Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure France Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure France Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure UK Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Italy Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Russia Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Thrombin (Human) Sales by Product (2013-2018) (K Units)
Table Europe Thrombin (Human) Sales Market Share by Product (2013-2018)
Figure 2017 Europe Thrombin (Human) Market Share by Product
Table Europe Thrombin (Human) Sales by End User (2013-2018) (K Units)
Table Europe Thrombin (Human) Sales Market Share by End User (2013-2018)
Figure 2017 Europe Thrombin (Human) Market Share by End User
Figure Asia Pacific Thrombin (Human) Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Thrombin (Human) Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Thrombin (Human) Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Thrombin (Human) Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Thrombin (Human) Sales Market Share by Countries
Table Asia Pacific Thrombin (Human) Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Thrombin (Human) Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Thrombin (Human) Revenue Market Share by Countries
Figure China Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure China Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Japan Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Korea Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure India Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure India Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Australia Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Thrombin (Human) Sales by Product (2013-2018) (K Units)
Table Asia Pacific Thrombin (Human) Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Thrombin (Human) Market Share by Product
Table Asia Pacific Thrombin (Human) Sales by End User (2013-2018) (K Units)
Table Asia Pacific Thrombin (Human) Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Thrombin (Human) Market Share by End User
Figure Central & South America Thrombin (Human) Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Thrombin (Human) Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Thrombin (Human) Sales by Countries (2013-2018) (K Units)
Table Central & South America Thrombin (Human) Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Thrombin (Human) Sales Market Share by Countries
Table Central & South America Thrombin (Human) Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Thrombin (Human) Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Thrombin (Human) Revenue Market Share by Countries
Figure Brazil Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Thrombin (Human) Sales by Product (2013-2018) (K Units)
Table Central & South America Thrombin (Human) Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Thrombin (Human) Market Share by Product
Table Central & South America Thrombin (Human) Sales by End User (2013-2018) (K Units)
Table Central & South America Thrombin (Human) Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Thrombin (Human) Market Share by End User
Figure Middle East and Africa Thrombin (Human) Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Thrombin (Human) Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Thrombin (Human) Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Thrombin (Human) Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Thrombin (Human) Sales Market Share by Countries
Table Middle East and Africa Thrombin (Human) Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Thrombin (Human) Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Thrombin (Human) Revenue Market Share by Countries
Figure GCC Countries Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Thrombin (Human) Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Thrombin (Human) Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Thrombin (Human) Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Thrombin (Human) Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Thrombin (Human) Market Share by Product
Table Middle East and Africa Thrombin (Human) Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Thrombin (Human) Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Thrombin (Human) Market Share by End User
Table Baxter Company Details
Table Baxter Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Baxter Recent Development
Table AMRESCO Inc Company Details
Table AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table AMRESCO Inc Recent Development
Table BD Biosciences Company Details
Table BD Biosciences Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table BD Biosciences Recent Development
Table Life Technologies Corporation Company Details
Table Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Life Technologies Corporation Recent Development
Table PromoCell GmbH Company Details
Table PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table PromoCell GmbH Recent Development
Table Sigma-Aldrich Corporation Company Details
Table Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sigma-Aldrich Corporation Recent Development
Table Vitrolife AB Company Details
Table Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Vitrolife AB Recent Development
Table CSL Company Details
Table CSL Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table CSL Recent Development
Table Bayer Company Details
Table Bayer Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Recent Development
Table Grifols Company Details
Table Grifols Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Grifols Recent Development
Table Octapharma Company Details
Table Shanghai RAAS Company Details
Table Hualan Biological Company Details
Table Global Thrombin (Human) Sales Forecast by Regions 2018-2025 (K Units)
Table Global Thrombin (Human) Sales Market Share Forecast by Regions 2018-2025
Table Global Thrombin (Human) Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Thrombin (Human) Revenue Market Share Forecast by Regions 2018-2025
Table Global Thrombin (Human) Sales Forecast by Product 2018-2025 (K Units)
Table Global Thrombin (Human) Sales Market Share Forecast by Product 2018-2025
Table Global Thrombin (Human) Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Thrombin (Human) Revenue Market Share Forecast by Product 2018-2025
Table Global Thrombin (Human) Sales Forecast by End User 2018-2025 (K Units)
Table Global Thrombin (Human) Sales Market Share Forecast by End User 2018-2025
Figure North America Thrombin (Human) Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Thrombin (Human) Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Thrombin (Human) Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Thrombin (Human) Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Thrombin (Human) Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Thrombin (Human) Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Thrombin (Human) Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Thrombin (Human) Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Thrombin (Human) Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Thrombin (Human) Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Thrombin (Human) Value Chain
Table Thrombin (Human) Customers List
Table Thrombin (Human) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
